Christopher U. Jones

Radiation Oncology Associates ORCID: 0000-0001-8880-5636

2

h-index

2

Publications

2,573

Citations

Publications

2 shown

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003

Karen K. Fu , Thomas F. Pajak , Andy Trotti +7 more

2000 International Journal of Radiation On... 1355 citations

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

Maura L. Gillison , Andy Trotti , Jonathan Harris +24 more

2018 The Lancet 1218 citations

Frequent Co-Authors

Maura L. Gillison

The Ohio State University

Andy Trotti

Moffitt Cancer Center

Jonathan Harris

RTOG Foundation

Avraham Eisbruch

University of Michigan

Paul M. Harari

UW Health University Hospital

David J. Adelstein

Cleveland Clinic

Researcher Info

h-index: 2
Publications: 2
Citations: 2,573
Institution: Radiation Oncology Associates

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-8880-5636

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.